A mouse model for developing treatment for secondary liver tumors

International Journal of Oncology

Volumn 27, Issue 1, 2005, Pages 113-120

  Cai, Shi Rong ^a,b   Garbow, Joel R ^a,b   Culverhouse, Robert ^a,b   Church, Robert D ^a   Zhang, Wanghai ^a,b   Shannon, William D ^a,b   McLeod, Howard L ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

Colorectal cancer; Developmental therapeutics; Mouse models; Systemic chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; IRINOTECAN;

ANIMAL; ARTICLE; COLORECTAL TUMOR; DISEASE MODEL; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER; LIVER TUMOR; MALE; METASTASIS; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PATHOLOGY; TIME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; TIME FACTORS;

EID: 24644459789     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.1.113     Document Type: Article

References (33)

1. Hasegawa S, Koshikawa N, Momiyama N, Moriyama K, Ichikawa Y, Ishikawa T, Mitsuhashi M, Shimada H and Miyazaki K: Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model. Int J Cancer 76: 812-816, 1998.
2. Wemyss-Holden SA, Robertson GS, Hall PD, Dennison AR and Maddern GJ: Electrolytic treatment of colorectal liver tumour deposits in a rat model: a technique with potential for patients with unresectable liver tumours. Dig Dis 18: 50-57, 2000.
3. Kobaek-Larsen M, Thorup I, Diederichsen A, Fenger C and Hoitinga MR: Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans. Comput Med 50: 16-26, 2000.
4. Fidler JJ: Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev 10: 229-243, 1991.
5. Hoffman RM: Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17: 343-359, 1999.
6. BresalierRS, Raper SE, Huj anen ES and Kim YS: A new animal model for human colon cancer metastasis. Int J Cancer 39: 625-630, 1987.
7. Yasui N, Sakamoto M, Ochiai A, Ino Y, Akimoto S, Orikasa A, Kitajima M and Hirohashi S: Tumor growth and metastasis of human colorectal cancer cell lines in SC1D mice resemble clinical metastatic behaviors. Invasion Metastasis 17: 259-269, 1997.
8. Leduc EH: Metastasis of transplantable hepatomas from the spleen to the liver in mice. Cancer Res 19: 1091-1095, 1959.
9. Tibbetts LM, Doremus CM, Tzanakakis GN and Vezeridis MP: Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production. Cancer 71: 315-321, 1993.
10. Moreno A, Lopez LA, Fabra A and Arus C: 1H MRS markers of tumour growth in intrasplenic tumours and liver metastasis induced by injection of HT-29 cells in nude mice spleen. NMR Biomed 11:93-106, 1998.
11. Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ and Ellis LM: Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 89: 488-499, 2000.
12. Dawiskiba J, Jeppsson B, Persson G, Hagerstrand I and Bengmark S: A model of colonic carcinoma with liver metastases in the rat. J Exp Clin Cancer Res 3: 269-273, 1983.
13. Furukawa T, Kubota T, Watanabe M, Kuo TH, Nishibori H, Kase S, Saikawa Y, Tanino H, Teramoto T, Ishibiki K, et al: A metastatic model of human colon cancer constructed using cecal implantation of cancer tissue in nude mice. Surg Today 23: 420-423, 1993.
14. Kuo TH, Kubota T, Watanabe M, Furukawa T, Teramoto T, Ishibiki K, Kitajima M, Moossa AR, Penman S and Hoffman RM: Liver colonization competence governs colon cancer metastasis. Proc Natl Acad Sei USA 92: 12085-12089, 1995.
15. Rashidi B, Gamagami R, Sasson A, Sun FX, Geller J, Moossa AR and Hoffman RM: An orthotopic mouse model of remetastasis of human colon cancer liver metastasis. Clin Cancer Res 6: 2556-2561,2000.
16. Bumpers HL, Alosco TR, Wang HQ, Petrelli NJ, Hoover EL and Bankert RB: Consistent hepatic metastasis of human colorectal cancer in severe combined immunodeficient mice. J Surg Res 61: 282-288, 1996.
17. Jain A, Slansky JE, Matey LC, Allen HE, Pardoll DM and Schulick RD: Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases. Ann Surg Oncol 10: 810-820, 2003.
18. Nordlinger B, Panis Y, Puts JP, Herve JP, Delelo R and Ballet F: Experimental model of colon cancer: recurrences after surgery alone or associated with intraperitoneal 5-fluorouracil chemotherapy. Dis Colon Rectum 34: 658-663, 1991.
19. Yang J, Shikata N, Mizuoka H and Tsubura A: Colon carcinogenesis in shrews by intrarectal infusion of N-methyl-Nnitrosourea. Cancer Lett 110: 105-112, 1996.
20. Wu M, Mazurchuk R, Chaudhary ND, Spernyak J, Veith J, Pera P, Greco W, Hoffman RM, Kobayashi T and Bernacki RJ: High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue l-[2-C-cyano-2-deoxy-beta-D- arabinopentofuranosyl]- N(4)-palmitoyl cytosine (CS-682) in a livermetastasis athymic nude mouse model. Cancer Res 63: 2477-2482, 2003.
21. Garbow JR, Dugas JP and Conradi MS: Respiratory gating for MRI and MRS in rodents, IEEE Symp. Bioinformat. BioEngineering 3: 126-129, 2003.
22. Garbow JR, Dugas JP, Song S-K and Conradi MS: A simple, robust hardware device for passive or active respiratory gating in MRI and MRS experiments. Concepts in Magnetic Resonance, Part B. Magn Reson Engineering (In press).
23. McLeod HL, McKay JA, Collie-Duguid ES and Cassidy J: Therapeutic opportunities from tumour biology in metastatic colon cancer. Eur J Cancer 36: 1706-1712, 2000.
24. Miyoshi E, Noda K, Ko JH, Ekuni A, Kitada T, Uozumi N, Ikeda Y, Matsuura N, Sasaki Y, Hayashi N, Hori M and Taniguchi N: Overexpression of alphal-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Res 59: 2237-2243, 1999.
25. Choi EA, Lei H, Maron DJ, Mick R, Barsoum J, Yu QC, Fraker DL, Wilson JM and Spitz FR: Combined 5-fluorouracil/ systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastases. Clin Cancer Res 10: 1535-1544,2004.
26. Hamblin MR, Del Governatore M, Rizvi I and Hasan T: Biodistribution of charged 17.1 A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br J Cancer 83: 1544-1551,2000.
27. Meyvisch C: Influence of implantation site on formation of metastases. Cancer Metastasis Rev 2: 295-306, 1983.
28. Anderson JH, Angerson WJ, Willmott N, Kerr DJ, McArdle CS and Cooke TG: Is there a relationship between regional microsphere distribution and hepatic arterial blood flow? Br J Cancer 66:287-289, 1992.
29. Nordlinger B and Panis Y: Les modales experimentaux de metastases hepatiques d'origine colorectale. Ann Chir 45: 222-228,1991.
30. Motwani M, Jung C, Sirotnak FM, She Y, Shah MA, Gonen M and Schwartz GK: Augmentation of apoptosis and tumor regression by flavopiridol in the presence of CPT-11 in Hctllcolon cancer monolayers and xenografts. Clin Cancer Res 7: 4209-4219,2001.
31. Prewett MC, Hooper AT, Bassi R, Ellis LM, Waksal HW and Hicklin DJ: Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts. Clin Cancer Res 8: 994-1003, 2002.
32. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL and Miller LL: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905-914, 2000.
33. Rothenberg ML, Eckardt JR, Kuhn JG, Burris HA III, Nelson J, Hilsenbeck SG, Rodriguez GI, Thurman AM, Smith LS, Eckhardt SG, Weiss GR, Elfring GL, Rinaldi DA, Schaaf LJ and von Hoff DD: Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol 14: 1128-1135, 1996.